Schetz M R, Van den Berghe G
Department of Intensive Care Medicine, Catholic University of Leuven, Leuven, Belgium.
Int J Artif Organs. 2005 Dec;28(12):1197-210. doi: 10.1177/039139880502801202.
Current outcome prediction in critically ill patients relies on the art of clinical judgement and/or the science of prognostication using illness severity scores. The biochemical processes underlying critical illness have increasingly been unravelled. Several biochemical markers reflecting the process of inflammation, immune dysfunction, impaired tissue oxygenation and endocrine alterations have been evaluated for their predictive power in small subpopulations of critically ill patients. However, none of these parameters has been validated in large populations of unselected ICU patients as has been done for the illness severity and organ failure scores. A simple biochemical predictor of ICU mortality will probably remain elusive because the processes underlying critical illness are very complex and heterogeneous. Future prognostic models will need to be far more sophisticated.
目前,危重症患者的预后预测依赖于临床判断的技巧和/或使用疾病严重程度评分的预后评估科学。危重症背后的生化过程已越来越多地被揭示。几种反映炎症、免疫功能障碍、组织氧合受损和内分泌改变过程的生化标志物已在危重症患者的小亚组中评估其预测能力。然而,这些参数中没有一个像疾病严重程度和器官衰竭评分那样在未选择的大量ICU患者中得到验证。由于危重症背后的过程非常复杂且具有异质性,ICU死亡率的简单生化预测指标可能仍然难以捉摸。未来的预后模型将需要更加复杂。